TTR and ovarian carcinoma: In conclusion, we have shown that ApoA-I, TF, and TTR, in combination with CA125 in a multivariate predictive model, have the potential to improve the specificity and sensitivity for the early detection of ovarian cancer over CA125 alone, particularly for the mucinous histopathologic subtype.